Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35 CAD
Market Closed
Updated:
May 5, 2024
Nuvo Pharmaceuticals Inc
Cash from Investing Activities
|
Nuvo Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
Cash from Investing Activities
-CA$301k
|
CAGR 3-Years
87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Investing Activities
-$2.1B
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
9%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Investing Activities
CA$293.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Investing Activities
-$59.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash from Investing Activities
-$114.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Cash from Investing Activities
-$27.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuvo Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-301k
CAD
-301k
CAD
Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Cash from Investing Activities amounts to -301k CAD.
What is Nuvo Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
87%
87%
Over the last year, the Cash from Investing Activities growth was 58%. The average annual Cash from Investing Activities growth rates for Nuvo Pharmaceuticals Inc have been 87% over the past three years .
You don't have any saved screeners yet
